Inventor · disambiguated record
Bai Liu
Also filed as: LIU BAI · LIU BAI-CHIA
39 granted patents·11 pending applications·581 citations·filing 2010–2025
98Inventor score
Files withALTOR BIOSCIENCE LLC31ALTOR BIOSCIENCE CORP9IMMUNITYBIO INC4WONG HING C2FERNANDEZ MARILYN1
Top patents by PatentIndex Score
50 records- 0199US11845783B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2021·Granted Dec 19, 2023·6 cites·5 claims
- 0299US11104716B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Aug 31, 2021·12 cites·17 claims
- 0399US11046747B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 29, 2021·18 cites·13 claims
- 0499US10150805B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Dec 11, 2018·44 cites·20 claims
- 0598US11992516B2Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodiesALTOR BIOSCIENCE LLC·Filed 2022·Granted May 28, 2024·3 cites·10 claims
- 0698US11925676B2Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complexALTOR BIOSCIENCE LLC·Filed 2023·Granted Mar 12, 2024·3 cites·23 claims
- 0798US11890323B2Method of treating cancer with composition comprising IL-15-based molecules and BCGALTOR BIOSCIENCE LLC·Filed 2022·Granted Feb 6, 2024·3 cites·6 claims
- 0898US11679144B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2022·Granted Jun 20, 2023·6 cites·9 claims
- 0998US11471511B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2020·Granted Oct 18, 2022·13 cites·7 claims
- 1098US11173191B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2019·Granted Nov 16, 2021·13 cites·8 claims
- 1198US10899821B2Method of treating neoplasia with a multimeric IL-15 soluble fusion moleculeALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 26, 2021·15 cites·21 claims
- 1298US10537615B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2018·Granted Jan 21, 2020·23 cites·7 claims
- 1398US10358478B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2016·Granted Jul 23, 2019·26 cites·18 claims
- 1498US9925247B2IL-15-based molecules and methods of use thereofALTOR BIOSCIENCE CORP·Filed 2015·Granted Mar 27, 2018·37 cites·25 claims
- 1598US9428573B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted Aug 30, 2016·56 cites·32 claims
- 1698US9328159B2Multimeric IL-15 soluble fusion molecules and methods of using sameALTOR BIOSCIENCE CORP·Filed 2013·Granted May 3, 2016·54 cites·9 claims
- 1798US9255141B2Multimeric IL-15 soluble fusion molecules and methods of treating neoplasia and HIV using sameWONG HING C·Filed 2013·Granted Feb 9, 2016·44 cites·16 claims
- 1898US8507222B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameWONG HING C·Filed 2011·Granted Aug 13, 2013·109 cites·6 claims
- 1997US11612645B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2022·Granted Mar 28, 2023·6 cites·4 claims
- 2097US11571470B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2021·Granted Feb 7, 2023·6 cites·5 claims
- 2197US11369679B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2020·Granted Jun 28, 2022·10 cites·16 claims
- 2297US11318201B2Multimeric IL-15-based moleculesALTOR BIOSCIENCE LLC·Filed 2021·Granted May 3, 2022·13 cites·9 claims
- 2397US11129883B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2018·Granted Sep 28, 2021·16 cites·14 claims
- 2497US10865230B2Construction and characterization of multimeric IL-15-based molecules with CD3 binding domainsALTOR BIOSCIENCE CORP·Filed 2017·Granted Dec 15, 2020·21 cites·15 claims
- 2596US11975059B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted May 7, 2024·2 cites·14 claims
- 2694US11872272B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 16, 2024·1 cites·7 claims
- 2793US12318432B2BCG and IL-15 based moleculesALTOR BIOSCIENCE LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 2893US12268732B2IL-15-based molecules with anti-CD20 antibody and methods of useALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·5 claims
- 2993US12268731B2Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG)ALTOR BIOSCIENCE LLC·Filed 2024·Granted Apr 8, 2025·0 cites·11 claims
- 3093US11053299B2SuperkineIMMUNITY BIO INC·Filed 2019·Granted Jul 6, 2021·16 cites·18 claims
- 3193US2024299498A1Method for stimulating tumor-infiltrating lymphocytes with an il-15:il-15r complexALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3292US12097244B2Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibodyALTOR BIOSCIENCE LLC·Filed 2023·Granted Sep 24, 2024·0 cites·23 claims
- 3391US12371472B2Multimeric IL-15 soluble fusion molecules and methods of making and using sameALTOR BIOSCIENCE LLC·Filed 2023·Granted Jul 29, 2025·0 cites·11 claims
- 3491US12233116B2IL-15-based fusions to IL-12 and IL-18ALTOR BIOSCIENCE LLC·Filed 2024·Granted Feb 25, 2025·0 cites·6 claims
- 3590US12024545B2Methods of treating aging-related disordersHCW BIOLOGICS INC·Filed 2021·Granted Jul 2, 2024·2 cites·78 claims
- 3689US12186372B2IL-15-based molecules and methods of treating a neoplasiaALTOR BIOSCIENCE LLC·Filed 2023·Granted Jan 7, 2025·0 cites·21 claims
- 3788US2024252609A1Il-15-based fusions to il-12 and il-18ALTOR BIOSCIENCE LLC·Filed 2024·Application pending·0 cites
- 3887US2025262277A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 3987US2025262278A1Il-15-based molecules and methods of use thereofALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 4075US2025152686A1Il-15-based fusions to il-12 and il-18ALTOR BIOSCIENCE LLC·Filed 2025·Application pending·0 cites
- 4173US9714279B2HIV vpr-specific T-cell receptorsALTOR BIOSCIENCE CORP·Filed 2014·Granted Jul 25, 2017·1 cites·26 claims
- 4273US2025011380A1Methods of treating aging-related disordersIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 4372US8933198B2HIV VPR-specific T cell receptorsFERNANDEZ MARILYN·Filed 2010·Granted Jan 13, 2015·2 cites·24 claims
- 4467US2025136663A1Multi-chain chimeric polypeptides and uses thereofIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 4563US2025295682A1Use of nucleotide of lactobacillus fermentum gm-090 for preparing pharmaceutical composition for regulating immunityGENMONT BIOTECH INC·Filed 2024·Application pending·0 cites
- 4662US10844107B2HIV VPR-specific T-cell receptorsALTOR BIOSCIENCE LLC·Filed 2017·Granted Nov 24, 2020·0 cites·6 claims
- 4762US2025108112A1Methods of generating, stimulating, or increasing proliferation of different subsets of cd8+ t cellsIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 4858US2018200366A1Multimeric il-15-based moleculesALTOR BIOSCIENCE CORP·Filed 2017·Application pending·0 cites
- 4952US12497462B2Anti-CD26 proteins and uses thereofIMMUNITYBIO INC·Filed 2021·Granted Dec 16, 2025·0 cites·21 claims
- 5038US2019048055A1Alt-803 in combination with anti-cd38 antibody for cancer therapiesALTOR BIOSCIENCE CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bai Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →